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حتليل ثانوي للمسح الصحي العاملي يف عمان
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abstract: Objectives: The study aimed to describe the prevalence of metabolic syndrome (MS) and its 
components among Omani adults. Methods: The 2008 Oman World Health Survey dataset was used to determine 
the national prevalence of MS. Logistic regression using all key sociodemographic, clinical and behavioural 
variables was used to identify the associations of independent variables with MS. Results: The age-adjusted 
prevalence of MS was 23.6%. MS was significantly associated with age, marital and work status and wealth level. 
MS was more common for people aged 50 years and older compared to the youngest cohort (OR 3.6, CI: 2.4–5.3; 
P <0.001) and in people who were married or employed (OR 1.6, CI: 1.3–2.1; P <0.001 and OR 1.3, CI: 1.1–1.8; 
P = 0.043, respectively) compared to their unmarried and unemployed counterparts. MS was also more common in 
people in the second lowest wealth quintile (OR 1.6, CI: 1.2–2.2; P = 0.05) compared to the lowest quintile and in 
those who sat for more than six hours per day (OR 1.3, CI: 1.1-1.7; P = 0.035). Conclusion: One in four adults had 
MS in Oman. This may fuel the epidemic of non-communicable diseases (NCDs) in Oman, particularly given the 
increasingly elderly population. Urgent action is required to ensure quality patient care at all levels of the healthcare 
system. Further research on behavioural risk factors is needed. Developing and implementing a multisectoral 
strategy to prevent NCDs should be at the top of the current health agenda for Oman.
Keywords: Metabolic Syndrome X; Chronic Diseases; Epidemiology; Public Health; Oman.
امللخ�ص: الهدف: هدفت الدرا�سة اإىل و�سف معدل انت�سار املتالزمة الأي�سية ومكوناتها بني العمانيني البالغني. الطريقة: مت ا�ستخدام قاعدة 
بيانات امل�سح ال�سحي العاملي بال�سلطنة لعام 2008 لتحديد املعدل الوطني لنت�سار املتالزمة الأي�سية، ومت ا�ستخدام معادلة النحدار 
للمتغريات  امل�ستقلة  العالقة  على  للتعرف  وال�سلوكيات  وال�رسيرية  ال�سكانية  الجتماعية-  للعوامل  الأ�سا�سية  املتغريات  لكل  اللوج�ستي 
امل�ستقلة مع املتالزمة الأي�سية. النتائج: وجد اأن معدل انت�سار املتالزمة الأي�سية املعدل ح�سب ال�سن يبلغ %23.6. ووجد اأي�سا ارتباط 
ذو دللة اإح�سائية مع العمر واحلالة الزواجية والعمل والرثوة. وكانت املتالزمة اأكرث انت�سارا بني الأفراد البالغني من العمر 50 عاما فاأكرث 
باملقارنة مع الفئة العمرية الأ�سغر )الحتمال املرجح: 3.6 وحدود الثقة P>0.001 ،2.4-5.3(. ووجد اأي�سا اأن املتالزمة الأي�سية 
اأكرث �سيوعا بني املتزوجني والعاملني ) الحتمال املرجح: 1.6 حدود الثقة P>0.001 ،1.3–2.1 والحتمال املرجح1.3 وحدود الثقة 
P = 0.043 ،1.1-1.8 على التوايل( مقارنة بغري املتزوجني والعاطلني عن العمل. كما وجد اأن املتالزمة اأكرث انت�سارا بني امل�ستوى 
الثاين الأقل من ترتيب اأخما�س الرثوة )الحتمال املرجح:1.6 وحدود الثقة P = 0.05 ،1.2-2.2) مقارنة بالفئة الأدنى. واأظهر اأي�سا 
الأفراد الذين يجل�سون لأكرث من 6 �ساعات يوميا عالقة ذات دللة معنوية مع املتالزمة الأي�سية )الحتمال املرجح: 1.3 وحدود الثقة 
P = 0.035 ،1.1-1.7(. اخلال�صة: وجد اأنه من بني كل اأربعة بالغني يف عمان يوجد �سخ�س واحد م�ساب باملتالزمة الأي�سية. وهذا 
مما يزيد من وبائية  الأمرا�س غري املعدية، خا�سة مع زيادة عدد امل�سنني. ويتطلب الأمر عمال عاجال ل�سمان توفري رعاية ذات جودة 
عالية للمر�سى على كل م�ستويات النظام ال�سحي، واجراء بحوث اأخرى على عوامل ال�سلوكيات الخاطئة ويجب تبني ا�سرتاتيجية متعددة 
القطاعات للوقاية من الأمرا�س غري املعدية وتنفيذها لتكون يف مقدمة الأجندة ال�سحية يف عمان. 
مفتاح الكلمات: املتالزمة الي�سية x؛ األمرا�س املزمنة؛ الوبائيات؛ ال�سحة العامة؛ عمان.
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Advances in Knowledge
- This is the first descriptive study at the national level in Oman of metabolic syndrome (MS), a precursor of cardiovascular disease and 
type 2 diabetes.
- One in four Omani adults was found to have MS. Furthermore, older adults, people who were married and those who were employed 
were observed to be some of the key high-risk groups for MS.
- From the results of this study, it was found that a large portion of Omani adults did not achieve the recommended amount of daily 
physical activity and did not consume the recommended amount of fruits and vegetables.
Application to Patient Care 
- The results of this study, which observed a high proportion of Omani adults with MS and its components, highlight the need for 
appropriate measures to ensure that the healthcare system can provide quality care, including prevention, screening for early diagnosis 
and management.
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Metabolic syndrome (MS) includes a cluster of cardiovascular and diabetes risk factors.1,2 People with this syndrome are at 
higher risk of developing diabetes and cardiovascular 
disease as well as premature mortality.1 MS also 
increases the risk of other diseases, including cancer, 
kidney disease and mental illness.3–5 Thus, MS is 
widely used as a marker for evaluating outcomes of 
population-based strategies aimed at preventing non-
communicable diseases.6
The first internationally recognised working 
definition for MS was proposed at a World Health 
Organization (WHO) consultation in 1988 and 
numerous attempts have been made since then to 
develop a standard definition. Most identified a person 
with MS as one who had at least three of the following: 
central obesity, high fasting blood glucose levels, 
elevated blood pressure (BP), high cholesterol and 
high triglycerides, with the main difference between 
definitions being the cut-off points for each of these 
clinical indicators.7 
Non-communicable diseases account for 83% of 
all deaths in Oman.8 Despite the increasing rates of 
overweight/obesity, hypertension and type 2 diabetes, 
limited information is known about MS in Oman.9–11 
A community-based study conducted in 2001 in 
Nizwa, Oman, reported an age-adjusted prevalence 
of 19.5% in men and 23.0% in women aged 20 years 
and older.12,13 A more recent survey in Sur, Oman, 
found the age-adjusted prevalence of MS to be 24.2% 
in men and 29.8% in women aged 20 years and above.14 
Despite the differences in age groups and definitions 
for MS, these studies demonstrate a clear gender 
difference, with a higher prevalence of MS in women, 
which is a trend that has been identified in other 
countries of the region as well.15 This study aimed to 
provide for the first time a descriptive epidemiology of 
MS and its components at the national level in Oman.
Methods
The World Health Survey was developed by the WHO 
more than 10 years ago to obtain comprehensive 
information on the health of a population using a 
standard methodology.16 The Oman World Health 
Survey (OWHS) was a population-based household 
survey conducted in 2008 to obtain a wide range 
of reliable and comparable information on the 
population’s health and healthcare system in Oman. 
The prevalence of non-communicable diseases and 
associated risk factors were captured by the survey. 
The OWHS used the WHO STEPwise approach.17 A 
multi-stage stratified cluster sampling design was used 
to select respondents aged 18 years and above.
Data were collected at the household level and 
included the following variables: gender, age, marital 
status (never married, currently married, separated/
divorced or widowed), education level (illiterate, 
primary/preparatory, secondary or post-secondary), 
work status (currently working, previously worked or 
never worked) and wealth (in quintiles, with quintile 1 
being the lowest and quintile 5 being the wealthiest). 
Respondents were asked to identify if they had ever 
been diagnosed with hypertension or diabetes and 
if so, whether they were taking medication or other 
treatments. Respondents were also asked about 
their health risk behaviours (tobacco use, physical 
inactivity, sitting time and fruit and vegetable intake). 
An individual who was a current user of any tobacco 
product was defined as a current smoker. Physical 
activity was assessed according to intensity, duration 
and frequency in three domains (work, transport and 
leisure); the total metabolic equivalent of task (MET) in 
minutes per day was calculated according to the WHO 
guidelines to estimate the total minutes of moderate 
physical activity per week for each individual. A 
person was determined as doing sufficient physical 
activity if they had performed the equivalent of at 
least 150 minutes of moderate physical activity per 
week. One survey item assessed the number of hours 
the participant sat per day. Fruit and vegetable intake 
was assessed by totalling the numbers of each item 
consumed on a typical day.
In addition, the anthropometrics (height, weight 
and waist circumference) of the respondents were 
assessed and three BP measurements were taken. 
Blood samples were collected after 8–14 hours of 
fasting to determine fasting blood glucose levels, total 
cholesterol levels, high-density lipoprotein (HDL) 
and low-density lipoprotein (LDL) cholesterol and 
triglyceride levels. The samples were labelled and 
transferred immediately in cold boxes filled with ice 
to a laboratory in a regional hospital. Samples for 
measuring blood glucose levels were collected in 2 
mL sodium fluoride oxalate anticoagulant containers 
and samples for measuring cholesterol were collected 
in 2 mL lithium heparin anticoagulant containers. 
After plasma separation by centrifuge, the blood 
glucose and lipid levels were estimated using a Hitachi 
911 automated clinical chemistry analyser (Roche 
Diagnostics, Basel, Switzerland) by the enzymatic 
colourimetric method.18
Out of the 5,465 individuals who were invited, a 
total of 4,717 individuals successfully completed the 
interviews with a response rate of 86.3%. Biomarkers 
were successfully analysed from 3,686 individuals 
(78.3%).9 Details of the study methodology have been 
published elsewhere.9 
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Among the participants, MS was identified using 
the National Cholesterol Education Program’s Revised 
Adult Treatment Panel III (ATPIII) definition.7 This 
identified individuals as having MS if they were taking 
medication for or had at least three of the following: 
central obesity with a waist circumference of ≥102 cm 
for men or ≥88 cm for women; raised triglycerides 
of ≥1.7 mmol/L; reduced HDL cholesterol  of <1.03 
mmol/L for men or <1.3 mmol/L for women; raised 
systolic BP of ≥130 mm Hg or diastolic BP of ≥85 mm, 
and raised fasting plasma glucose of ≥5.6 mmol/L.7 In 
addition to central obesity, obesity was also assessed 
using body mass index (BMI) calculated in kg/m2. 
The prevalence of MS was examined according to 
sociodemographic and behavioural risk factors for 
Omani participants with complete information for all 
adults aged 20 years and above.
Data were entered on microcomputers using 
the Census and Survey Processing (CSPro) System 
(United States Census Bureau, Washington, D.C., 
USA). Survey data were cleaned using CSPro as well 
as Stata, Version 13 (StataCorp LP, College Station, 
Texas, USA). The Statistical Package for the Social 
Sciences (SPSS), Version 18 (IBM Corp., Chicago, 
Illinois, USA) was used for statistical analysis. Logistic 
regression using all key sociodemographic, clinical 
and behavioural variables determined the associations 
of independent variables with MS. Models were age-
adjusted to the population of Oman using national 
2008 population statistics. Results were reported as 
percentages, means with standard deviations (SD) and 
odds ratios (OR) with 95% confidence intervals (CI). 
This secondary analysis of the OWHS for chronic 
non-communicable diseases and associated risk 
factors was approved by the Research and Ethical 
Review and Approval Committee of the Ministry of 
Health (MOH).
Results
A total of 3,137 Omani participants had complete 
information for all of the variables and were included 
in this study (85%). The sample was relatively young 
(39.4 ± 15.8 years) and 46.5% were men. Nearly two-
thirds (63.4%) of the participants were married [Table 
1]. Approximately half of the men (49.5%) had received 
at least a secondary school education compared to only 
34.7% of the women, and a larger proportion of men 
(60.3%) were employed compared to women (10.7%).
The mean BMI and systolic BP measurements of 
the sample were higher than normal at 26.1 ± 6.5 kg/
m2 and 131.8 ± 21.9 mm Hg, respectively. Elevated 
means were observed among men for BMI, systolic BP, 
Table 1: Distribution of selected sociodemographic, metabolic and 
lifestyle characteristics by gender of the Omani population sample 







Age group in 
years
20–29 36.5 32.1 34.2
30–39 23.7 27.0 25.5
40–49 14.8 13.6 14.1
50–59 10.0 14.5 12.4
≥60 15.1 12.8 13.8
Mean ± SD 39.4 ± 16.6 39.5 ± 15.1 39.4 ± 15.8













Work status Employed 60.3 10.7 33.8
Wealth 
status†
Q1 16.5 17.7 17.1
Q2 23.1 25.0 24.1
Q3 22.1 22.6 22.4
Q4 18.6 20.4 19.6
Q5 19.7 14.2 16.8
Metabolic components
BMI in kg/m2 25.9 ± 6.3 26.3 ± 6.6 26.1 ± 6.5
WC in cm 90.5 ± 15.8 89.6 ± 17.8 90.0 ± 16.9
SBP in mm Hg 138.4 ± 21.4 126.0 ± 20.8 131.8 ± 21.9
DBP in mm Hg 84.9 ± 14.3 77.0 ± 13.4 80.7 ± 14.4
FBG in mmol/L 5.7 ± 2.2 5.4 ± 1.9 5.5 ± 2.1
Triglycerides in mmol/L 1.40 ± 1.1 1.17 ± 0.8 1.30 ± 0.9
HDL cholesterol in mmol/L 1.18 ± 0.3 1.36 ± 0.4 1.26 ± 0.4
Lifestyle characteristics
Current smoker 15.1 0.3 7.2
<150 minutes of moderate 
physical activity/week
32.0 40.5 36.6
>6 hours sitting per day 21.5 25.6 23.7
Median sitting time in hours/
day
3.0 4.0 3.0
<5 servings of fruit/
vegetables per day
84.6 80.9 82.6
Servings of fruit/vegetables 
per day
3.0 ± 2.3 3.2 ± 2.7 3.1 ± 2.5
Q = quintile; SD = standard deviation; BMI = body mass index; WC = waist 
circumference; SBP = systolic blood pressure; DBP = diastolic blood pressure; FBG = 
fasting blood glucose; HDL = high-density lipoprotein.*Data is expressed as unweighted 
percentages or mean ± SD. †Wealth status was divided into quintiles, with Q1 being the 
lowest and Q5 being the wealthiest.
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blood glucose and triglycerides levels in comparison 
to women, where these variables were within normal 
ranges. However, women’s obesity measurements 
were outside these normal ranges. The mean waist 
circumferences of women (89.6 ± 17.8 cm) were above 
the normal range and similar to those of men (90.5 ± 
15.8 cm).
A high percentage of the sample ate less than the 
recommended five servings of fruit and vegetables per 
day (82.6%) and did less than 150 minutes of moderate 
physical activity per week (36.6%). Tobacco use was 
relatively common among men (15.1%) but rare 
among women (0.3%).
Overall, the age-adjusted prevalence of MS was 
23.6%; it was slightly higher in women (24.4%) than 
men (22.8%), but this difference was not statistically 
significant [Table 2]. The age-adjusted prevalence of 
MS was particularly high in adults aged 40–49 years 
(33.4%), those aged 50 years and above (39.5%) and 
those with no formal education (33.7%).
The prevalence of the various components of MS 
varied according to gender [Figure 1]. The components 
with the highest prevalence for women were central 
obesity and low HDL cholesterol (73.7% and 59.8%, 
respectively). For men, the components with the 
highest prevalence were high BP, high triglycerides 
and impaired fasting glucose levels (60.1%, 56.4% 
and 53.0%, respectively). The gender difference 
in prevalence rates were highly significant for all 
components (P <0.001). 
Table 2 presents the results of the logistic regress-
ion analysis using all key sociodemographic, clinical 
and behavioural variables. MS was significantly 
associated with age, wealth and marital and work 
status. MS was more common for people aged 50 years 
Table 2: Adjusted prevalence and odds ratio of 
demographic and behavioural risk factors for metabolic 
syndrome* in the Omani population using the 2008 














Women 1,678 24.4 1 -
Men 1,459 22.8 0.9 
(0.7–1.2)
0.539

































































































































































































Total 3,173 23.6 - - 
OR = odds ratio; CI = confidence interval; Q = quintile. 
*Metabolic syndrome was identified according to the National 
Cholesterol Education Program’s Revised Adult Treatment Panel III 
definition. †Wealth status was divided into quintiles, with Q1 being the 
lowest and Q5 being the wealthiest.
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and over compared to the youngest cohort (OR 3.6, 
CI: 2.4–5.3; P <0.001). It was more common in people 
who were married or employed (OR 1.6, CI: 1.3–2.1; P 
<0.001 and OR 1.3, CI: 1.1–1.8; P = 0.043, respectively) 
compared to their unmarried and unemployed 
counterparts. MS was also more common in people 
in the second lowest wealth quintile (OR 1.6, CI: 1.2–
2.2; P = 0.005) compared to the lowest quintile. Of the 
behavioural risk factors examined (smoking, physical 
activity, sitting time and dietary intake), only sitting 
time showed a significant association with MS. The 
syndrome was more common in people who sat more 
than six hours per day in comparison to those who sat 
less (OR 1.3, CI: 1.1–1.7; P = 0.035).
Discussion
The results of this study showed a high national 
prevalence of MS (23.6%). This prevalence differed 
from other prevalences recorded in Oman—it was 
slightly higher than that seen in Nizwa in 2001 (21.0%) 
but lower than that seen in Sur (27.3%).12,14 These 
differences could be due to the definition of MS that 
was used in these studies. The prevalence found 
was also slightly lower than in Qatar (26.5%), but 
much lower than prevalences recorded among other 
countries of the Gulf Cooperation Council (GCC) 
region, like Saudi Arabia (39.3%) and the United Arab 
Emirates (UAE) (39.6%).15 Like Oman, other countries 
of the GCC region reported a higher prevalence of 
MS among women, with gender differences ranging 
between 4.8% in Saudi Arabia using the ATPIII 
definition to 13% in the UAE using the International 
Diabetes Federation definition.15 The prevalence 
rates in Oman were lower than in the USA, where 
the rates were 35.1% and 32.6% for men and women, 
respectively.19 However, the rates for men and women 
were higher than those found in Australia (15.7% and 
14.4%, respectively)20 and European countries such as 
Italy (15% and 18%, respectively)21 and France (16% 
and 11%, respectively).22 The lower prevalence seen 
in Oman compared to neighbouring countries is 
likely due to the lower rates of obesity and possibly 
also a reflection of the relatively lower gross domestic 
product (GDP) per capita.23
It is concerning that despite having a young 
population compared to developed countries, one in 
four Omani adults in the 2008 OWHS were found 
to have MS. The prevalence of non-communicable 
diseases and their risk factors, such as obesity and high 
BP, are on the increase.9–11 Evidence indicates that the 
Omani population is genetically susceptible to some 
components of MS such as obesity, high cholesterol 
levels and elevated BP.24 In addition, evidence indicates 
that malnutrition in utero, a likely scenario for the 
current generation of adults, is linked to MS in adults.25 
Given the population’s increased vulnerability to MS, 
extensive efforts should be made by the government 
of Oman to implement multisectoral, cost-effective, 
population-wide interventions such as the actions 
outlined in the United Nations’ Political Declaration 
of the High-level Meeting of the General Assembly 
on the Prevention and Control of Non-communicable 
Diseases.8,26
Interestingly, of the behavioural risk factors 
examined (smoking, physical inactivity, sitting time 
 
Figure 1: The age-adjusted prevalence of various components of metabolic syndrome among men and women using the 
2008 Oman World Health Survey. Metabolic syndrome was defined according to the National Cholesterol Education 
Program’s Revised Adult Treatment Panel III criteria. The error bars denote 95% confidence intervals.
HDL = high-density lipoproteins. ***Significance was P <.001. 
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and dietary intake), only sitting time was found to 
be associated with MS in this study. Evidence clearly 
demonstrates that these behaviours can prevent MS 
and its components.8,14,27,28 Thus, it is concerning 
that a large portion of Omani adults do not meet the 
recommended amount of physical activity, sit for long 
periods of time and do not consume the recommended 
amount of fruit and vegetables.8,29 Successful 
interventions within the GCC region, including 
the Nizwa Healthy Lifestyle Project, demonstrate 
how community-based activities can bring about 
behavioural changes.30,31 A more strategic approach to 
promoting physical activity and healthy eating involves 
changes in policies which are largely outside the health 
sector, such as agriculture, commerce, education, 
media, sports, transportation and urban planning.32
The high proportion of adults suffering from 
MS and its components is likely to increase in the 
near future given the increase in life expectancy and 
the high susceptibility of the population. Despite 
the existence of well-defined clinical management 
guidelines and a national screening programme for 
non-communicable diseases,33–35 several studies have 
raised concerns regarding the quality of care for 
people with diabetes.31,36,37 Improving the delivery of 
care, patient education and training for health workers 
at the primary care level have been identified as key 
areas for improvement.36,37
The significant associations of MS with older age 
and lower education are similar to the findings of other 
studies in Oman and other GCC countries.12,15,38,39 The 
positive association with age is also commonly found 
in other parts of the world.40 However, the association 
with education and income varies internationally.40 
Given the significant associations with age and 
education in Oman, the growth of the elderly 
population and a high proportion of older adults 
with MS, extensive efforts are required to ensure that 
prevention and disease management messages can be 
clearly understood and followed by all, including those 
with limited literacy skills.41 Improving the quality of 
care by emphasising a patient-centred approach is a 
key way to address this particular issue.36,37
The main strength of this study is that it was 
a population-based study with a large sample. 
By obtaining information and collecting clinical 
measurements and blood at the household level, 
participants were not obligated to visit a health centre. 
On the other hand, the long questionnaire, which 
required an average of 2.25 hours to complete, may 
have wearied respondents and potentially lead to 
inaccuracy, particularly among self-reported items 
such as the questions regarding health risk behaviours. 
In addition, as a cross-sectional study, the associations 
identified do not necessarily denote causality.
Four main recommendations can be made based 
on the findings of this study. First, greater efforts 
should be made by the MOH to advocate for an 
all-government approach to promoting healthy 
behaviours as part of a national strategy to prevent 
non-communicable diseases and their precursor, MS. 
Given the vast amount of evidence demonstrating that 
physical activity and healthy dietary behaviours can 
prevent MS and its components, further research is 
recommended to better understand these behaviours 
and to test interventions. Additionally, a patient-
centred approach that ensures the provision of 
quality primary healthcare interventions to prevent, 
screen for and manage MS and its components 
is required in order to prevent complications and 
reduce hospitalisation and mortality. Prevention and 
disease management messages need to be developed 
so that they can be easily understood and followed, 
particularly by older adults who may have limited 
literacy skills.
Conclusion
In conclusion, one in four Omani adults was found 
to have MS, which is a proximal precursor to 
cardiovascular disease and diabetes. This prevalence 
rate is higher than in many developed countries despite 
the much younger population in Oman. An enormous 
amount of effort by various sectors is needed to reduce 
the prevalence of MS and its components in order to 
build on the health gains of the past and to meet the 
country’s United Nations commitments to addressing 
non-communicable diseases.
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